Caveats on COVID-19 herd immunity threshold: the Spain case

被引:0
|
作者
David García-García
Enrique Morales
Eva S. Fonfría
Isabel Vigo
Cesar Bordehore
机构
[1] University of Alicante,Department of Applied Mathematics
[2] University of Alicante,Multidisciplinary Institute for Environmental Studies “Ramon Margalef”
[3] University of Alicante,Department of Ecology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
After a year of living with the COVID-19 pandemic and its associated consequences, hope looms on the horizon thanks to vaccines. The question is what percentage of the population needs to be immune to reach herd immunity, that is to avoid future outbreaks. The answer depends on the basic reproductive number, R0, a key epidemiological parameter measuring the transmission capacity of a disease. In addition to the virus itself, R0 also depends on the characteristics of the population and their environment. Additionally, the estimate of R0 depends on the methodology used, the accuracy of data and the generation time distribution. This study aims to reflect on the difficulties surrounding R0 estimation, and provides Spain with a threshold for herd immunity, for which we considered the different combinations of all the factors that affect the R0 of the Spanish population. Estimates of R0 range from 1.39 to 3.10 for the ancestral SARS-CoV-2 variant, with the largest differences produced by the method chosen to estimate R0. With these values, the herd immunity threshold (HIT) ranges from 28.1 to 67.7%, which would have made 70% a realistic upper bound for Spain. However, the imposition of the delta variant (B.1.617.2 lineage) in late summer 2021 may have expanded the range of R0 to 4.02–8.96 and pushed the upper bound of the HIT to 90%.
引用
收藏
相关论文
共 50 条
  • [1] Caveats on COVID-19 herd immunity threshold: the Spain case
    Garcia-Garcia, David
    Morales, Enrique
    Fonfria, Eva S.
    Vigo, Isabel
    Bordehore, Cesar
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [2] Difficult to Determine Herd Immunity Threshold for COVID-19
    Rubin, Rita
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (08): : 732 - 732
  • [3] Herd immunity for COVID-19
    Burki, Talha Khan
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (02): : 135 - 136
  • [4] COVID-19 and Herd Immunity
    Alp, Sehnaz
    Altintas, Hakan
    [J]. FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (02): : 232 - 237
  • [5] Herd immunity and COVID-19
    Chen, J.
    Ye, L.
    Zhou, M. -Y.
    Cheng, Y. -R.
    Wang, M. -W.
    Feng, Z. -H.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (08) : 4064 - 4065
  • [6] COVID-19 and herd immunity
    Ashton, John
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2022, 115 (02) : 76 - 77
  • [7] Universality and herd immunity threshold: Revisiting the SIR model for COVID-19
    Chowdhury, Sourav
    Roychowdhury, Suparna
    Chaudhuri, Indranath
    [J]. INTERNATIONAL JOURNAL OF MODERN PHYSICS C, 2021, 32 (10):
  • [8] Timeliness and obsolescence of herd immunity threshold estimates in the COVID-19 pandemic
    Gomes, M. G. M.
    [J]. PUBLIC HEALTH, 2022, 205 : E3 - E4
  • [9] Role of Herd Immunity in COVID-19
    Ruchi
    Chakole, Swarupa
    Reddy, Himabindu
    Mehendale, Ashok
    [J]. JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2022, 10 (08): : 258 - 262
  • [10] Digital herd immunity and COVID-19
    Bulchandani, Vir B.
    Shivam, Saumya
    Moudgalya, Sanjay
    Sondhi, S. L.
    [J]. PHYSICAL BIOLOGY, 2021, 18 (04)